US Stock MarketDetailed Quotes

Verrica Pharmaceuticals (VRCA)

Watchlist
  • 7.555
  • -0.175-2.26%
Trading Jan 23 14:21 ET
120.80MMarket Cap-2.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verrica Pharmaceuticals (VRCA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
Net income from continuing operations
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
Operating gains losses
--34K
---420K
---254K
7.65%2.73M
4.60%2.59M
--0
----
----
76.55%2.54M
--2.48M
Depreciation and amortization
-46.20%184K
-40.42%199K
-38.82%208K
51.79%1.27M
16.59%253K
62.86%342K
61.35%334K
68.32%340K
16.43%836K
7.96%217K
Other non cash items
31.01%1.09M
34.11%692K
38.92%671K
172.35%2.21M
-20.55%375K
--832K
--516K
--483K
108.23%810K
4,190.91%472K
Change In working capital
-28.01%7.93M
-385.45%-11.61M
-82.64%-4.59M
-79.44%2.03M
-184.06%-4.09M
4,021.71%11.02M
-152.32%-2.39M
-457.18%-2.51M
647.72%9.86M
1,269.95%4.87M
-Change in receivables
-2.29%10.04M
-348.11%-11.72M
-75.51%-5.58M
210.44%4.34M
57.56%-146K
363.58%10.28M
-2,135.04%-2.62M
-837.12%-3.18M
-706.78%-3.93M
-405.88%-344K
-Change in inventory
--218K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
-1,953.10%-2.09M
180.71%272K
142.82%546K
-292.16%-1.13M
188.33%371K
106.00%113K
-120.74%-337K
-200.71%-1.28M
228.73%587K
41.67%-420K
-Change in payables and accrued expense
-270.15%-1.24M
-178.91%-505K
-74.26%520K
-106.39%-862K
-174.57%-4.25M
-86.97%727K
-79.59%640K
319.57%2.02M
2,375.21%13.49M
1,189.14%5.7M
-Change in other current liabilities
18.56%-79K
1.27%-78K
3.80%-76K
-10.65%-322K
0.00%-67K
-25.97%-97K
-8.22%-79K
-6.76%-79K
-10.23%-291K
4.29%-67K
-Change in other working capital
--1.08M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
Investing cash flow
Cash flow from continuing investing activities
0
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
0
-100.67%-362K
-103.36%-227K
Net PPE purchase and sale
--0
----
----
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
-19.87%-362K
-243.94%-227K
Cash from discontinued investing activities
Investing cash flow
--0
----
----
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
-100.67%-362K
-103.36%-227K
Financing cash flow
Cash flow from continuing financing activities
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
140,907.14%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
-28K
Net issuance payments of debt
-1,735.94%-3.98M
-1,351.51%-4.16M
-510.08%-4.06M
-104.68%-2.06M
-6,482.61%-1.51M
-100.49%-217K
--332K
---665K
200.75%44.08M
---23K
Net common stock issuance
----
----
----
30.82%39.64M
3,963,800.00%39.64M
--0
--0
--0
12.64%30.3M
---1K
Proceeds from stock option exercised by employees
--0
--0
--0
2,114.29%155K
--1K
--0
--150K
-42.86%4K
--7K
--0
Net other financing activities
----
----
----
----
----
-195.08%-180K
----
----
-935.29%-176K
---3K
Cash from discontinued financing activities
Financing cash flow
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
146,122.22%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
---27K
Net cash flow
Beginning cash position
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
102.92%69.55M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
117.58%34.27M
159.62%84.31M
Current changes in cash
163.55%5.7M
16.52%-14.2M
18.80%-16.73M
-165.82%-23.22M
258.32%23.37M
-130.76%-8.97M
-253.47%-17.01M
-180.25%-20.61M
90.45%35.27M
-920.06%-14.76M
End cash Position
-8.11%21.1M
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
-33.38%46.33M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
102.92%69.55M
Free cash flow
212.96%9.69M
38.64%-10.04M
36.45%-12.68M
-56.54%-60.95M
-9.03%-16.06M
42.36%-8.57M
-246.21%-16.37M
-333.54%-19.95M
-105.46%-38.94M
-193.51%-14.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M-106.85%-38.58M-192.83%-14.51M
Net income from continuing operations 98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M-208.56%-20.33M-173.59%-67M-314.94%-24.61M
Operating gains losses --34K---420K---254K7.65%2.73M4.60%2.59M--0--------76.55%2.54M--2.48M
Depreciation and amortization -46.20%184K-40.42%199K-38.82%208K51.79%1.27M16.59%253K62.86%342K61.35%334K68.32%340K16.43%836K7.96%217K
Other non cash items 31.01%1.09M34.11%692K38.92%671K172.35%2.21M-20.55%375K--832K--516K--483K108.23%810K4,190.91%472K
Change In working capital -28.01%7.93M-385.45%-11.61M-82.64%-4.59M-79.44%2.03M-184.06%-4.09M4,021.71%11.02M-152.32%-2.39M-457.18%-2.51M647.72%9.86M1,269.95%4.87M
-Change in receivables -2.29%10.04M-348.11%-11.72M-75.51%-5.58M210.44%4.34M57.56%-146K363.58%10.28M-2,135.04%-2.62M-837.12%-3.18M-706.78%-3.93M-405.88%-344K
-Change in inventory --218K------------------0----------------
-Change in prepaid assets -1,953.10%-2.09M180.71%272K142.82%546K-292.16%-1.13M188.33%371K106.00%113K-120.74%-337K-200.71%-1.28M228.73%587K41.67%-420K
-Change in payables and accrued expense -270.15%-1.24M-178.91%-505K-74.26%520K-106.39%-862K-174.57%-4.25M-86.97%727K-79.59%640K319.57%2.02M2,375.21%13.49M1,189.14%5.7M
-Change in other current liabilities 18.56%-79K1.27%-78K3.80%-76K-10.65%-322K0.00%-67K-25.97%-97K-8.22%-79K-6.76%-79K-10.23%-291K4.29%-67K
-Change in other working capital --1.08M------------------------------------
Cash from discontinued investing activities
Operating cash flow 213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M-106.85%-38.58M-192.83%-14.51M
Investing cash flow
Cash flow from continuing investing activities 094.75%-19K103.52%8K75.38%-16K81.36%-11K0-100.67%-362K-103.36%-227K
Net PPE purchase and sale --0--------94.75%-19K103.52%8K75.38%-16K81.36%-11K--0-19.87%-362K-243.94%-227K
Cash from discontinued investing activities
Investing cash flow --0--------94.75%-19K103.52%8K75.38%-16K81.36%-11K--0-100.67%-362K-103.36%-227K
Financing cash flow
Cash flow from continuing financing activities -903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M140,907.14%39.43M-100.90%-397K-661.90%-640K-102.18%-661K539.91%74.21M-28K
Net issuance payments of debt -1,735.94%-3.98M-1,351.51%-4.16M-510.08%-4.06M-104.68%-2.06M-6,482.61%-1.51M-100.49%-217K--332K---665K200.75%44.08M---23K
Net common stock issuance ------------30.82%39.64M3,963,800.00%39.64M--0--0--012.64%30.3M---1K
Proceeds from stock option exercised by employees --0--0--02,114.29%155K--1K--0--150K-42.86%4K--7K--0
Net other financing activities ---------------------195.08%-180K---------935.29%-176K---3K
Cash from discontinued financing activities
Financing cash flow -903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M146,122.22%39.43M-100.90%-397K-661.90%-640K-102.18%-661K539.91%74.21M---27K
Net cash flow
Beginning cash position -51.78%15.4M-39.53%29.6M-33.38%46.33M102.92%69.55M-72.77%22.96M-42.09%31.93M-18.37%48.94M102.92%69.55M117.58%34.27M159.62%84.31M
Current changes in cash 163.55%5.7M16.52%-14.2M18.80%-16.73M-165.82%-23.22M258.32%23.37M-130.76%-8.97M-253.47%-17.01M-180.25%-20.61M90.45%35.27M-920.06%-14.76M
End cash Position -8.11%21.1M-51.78%15.4M-39.53%29.6M-33.38%46.33M-33.38%46.33M-72.77%22.96M-42.09%31.93M-18.37%48.94M102.92%69.55M102.92%69.55M
Free cash flow 212.96%9.69M38.64%-10.04M36.45%-12.68M-56.54%-60.95M-9.03%-16.06M42.36%-8.57M-246.21%-16.37M-333.54%-19.95M-105.46%-38.94M-193.51%-14.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.11%
Sample Name
Sample Code
 +2.52%
Sample Name
Sample Code
 +2.41%
4
Block
XYZ
+2.40%
5
Amazon
AMZN
+2.30%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +8.12%
Sample Name
Sample Code
 +4.54%
4
H World Group
HTHT
+4.43%
5
KE Holdings
BEKE
+4.36%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -